Myopia Profile Sign in Sign in

Light therapies for myopia control .

Light therapies for myopia control are a relatively new addition to science and practice. The most well-known, with the widest evidence-base, is repeated low-level red light (RLRL) therapy (650nm). This has mounting evidence for slowing myopia onset and progression in children, including those with high myopia and fast observed progression in orthokeratology wear. 

New light therapies on the horizon include use of cyan light-emitting glasses (507nm), bright (white) light desktop devices, and a pre-commercial VR-like headset delivering targeted light to the optic nerve. Keep up to date with the latest on light therapies here! 

See all myopia control products

Light therapy for myopia control articles.

Hot topics in myopia for 2025Light therapiesAtropineHot topics in myopia for 2025We explore five key topics which we are set to learn more about in the year ahead from pre-myopia to atropine to light therapies, and more. Read full article Global insights on repeated low-level red light therapy: interview series Myopia control efficacyGlobal insights on repeated low-level red light therapy: interview series A recent interview series with five experts from around the world sheds light on their experiences with RLRL. Read full article APAO Showcase: The Latest on Repeated Low-Level Red Light TherapyLight therapiesAPAO Showcase: The Latest on Repeated Low-Level Red Light TherapyThe APAO congress featured the newest research on red light therapy; here, we summarise the evidence. Read full article Real-world cases with red light therapyManaging treatment outcomesReal-world cases with red light therapyFour real-world cases show how repeated low-level red-light (RLRL) therapy can be a powerful tool for myopia management.Read full article Reducing RLRL intensity maintains choroidal thickeningLight therapiesReducing RLRL intensity maintains choroidal thickeningLower-intensity red-light achieved similar choroidal thickening after one month, supporting further research into reduced-dose RLRL for myopia control.Read full article MyopiaX: a new blue-light therapy for myopiaLight therapiesMyopiaX: a new blue-light therapy for myopiaThis new blue-light therapy targets retinal dopamine and melanopsin through ganglion cells, using a smartphone app and VR headset. Read full article Three key myopia questions for 2026 Light therapiesAtropineThree key myopia questions for 2026 Atropine 0.01% monotherapy, second generation spectacle lenses and light therapy combo treatments - much to learn!Read full article Repeated low-level red light and ortho-k combined: first European dataLight therapiesRepeated low-level red light and ortho-k combined: first European dataCombining RLRL with ortho-k slowed eye growth by 0.23 mm in Spanish children, with 80% showing axial shortening after 12 months.Read full article The impact of rebound in myopia controlAxial lengthThe impact of rebound in myopia controlRebound can be miscalculated in myopia control. This review explains the correct approach and finds minimal rebound for optical treatments, but more for pharmacological ones.Read full article Meta-analysis on RLRL slowing eye growth in myopiaAxial lengthMeta-analysis on RLRL slowing eye growth in myopiaA meta-analysis of 10 randomized controlled trials showed that RLRL therapy slows myopia progression and axial elongation over one year.Read full article Comparing the rebound effects of myopia control interventionsSoft contact lensesComparing the rebound effects of myopia control interventionsThis review compared rebound effects among different myopia control treatments, finding less rebound with optical options than atropine or light therapies.Read full article  ARVO2025 Recap #3 - Newest data on atropine and light therapiesLight therapiesAtropine ARVO2025 Recap #3 - Newest data on atropine and light therapiesThis third recap goes through novel light therapies and new research on atropine from ARVO 2025.Read full article Tighter regulation of RLRL devices for myopia in ChinaLight therapiesTighter regulation of RLRL devices for myopia in ChinaChina reclassifies RLRL devices as high-risk, suspending their use pending stricter safety and efficacy data.Read full article Comparing different power levels of low-level red light for myopia managementLight therapiesComparing different power levels of low-level red light for myopia managementDifferent power levels of low-level red light therapy showed a trend towards but didn't confirm a dose-response effect. Read full article Combining forces: the latest on combination treatments in myopia managementCombination treatmentCombining forces: the latest on combination treatments in myopia managementCombination therapy in myopia shows promise, with some approaches well-supported and others still under study.Read full article How to identify and manage pre-myopesUntreated myopia progressionHow to identify and manage pre-myopesHow can we identify and manage children at high risk of myopia onset? Definitions, communication and options are described.Read full article Efficacy of repeated low-level red light therapy for high myopia control Light therapiesEfficacy of repeated low-level red light therapy for high myopia control This study found strong efficacy for high myopia and no adverse responses after 1 year of low-level red light therapy use.Read full article Latest on Interventions for Myopia Management from IMC 2024Ortho-kLight therapiesLatest on Interventions for Myopia Management from IMC 2024A central focus of the 2024 IMC was the latest research on interventions for myopia management.Read full article Boosting orthokeratology efficacy with repeated low-level red lightOrtho-kLight therapiesBoosting orthokeratology efficacy with repeated low-level red lightThis 1-year study investigated the efficacy and safety of combining orthokeratology and repeated low-level red-light (RLRL) therapyRead full article Can red light therapy delay myopia onset?Pre-myopiaCan red light therapy delay myopia onset?This study found lower myopia incidence and no ocular damage in pre-myopic children using repeated red-light therapy over 12 monthsRead full article Repeated low-level red light therapy: a look at safety and efficacyMyopia control efficacyRepeated low-level red light therapy: a look at safety and efficacyRepeated low-level red light (RLRL) therapy is a new approach to myopia control: read about the research on safety and efficacy. Read full article Repeated low-level red light therapy in the clinic: Q&A with Song Chow, Jagrut Lallu and Simon RoseLight therapiesRepeated low-level red light therapy in the clinic: Q&A with Song Chow, Jagrut Lallu and Simon RoseThree leading eyecare clinicians discuss using repeated low-level red light (RLRL) therapy in their practice. Read full article Follow-up on red-light: safety, efficacy and the rebound effectTreatment safetyFollow-up on red-light: safety, efficacy and the rebound effectRepeated low-level red light therapy is an efficacious myopia control intervention and also carries a rebound effect. Read full article Is red light therapy safe and effective for myopia control?Light therapiesIs red light therapy safe and effective for myopia control?Repeated low-level red light (RLRL) therapy is showing impressive results for myopia control in children, but is it safe? Read more here.Read full article Light-emitting glasses alter axial length and choroidal thickness in young adultsAxial lengthSpectaclesLight-emitting glasses alter axial length and choroidal thickness in young adultsLight-emitting glasses worn by young adults for 1-2 hours reduced axial length and increased choroidal thickness. A future myopia treatment?Read full article 

Light therapy for myopia control treatments.

Myopia management products

Myopia management products listed by Myopia Profile have been specifically designed for myopia control or myopia management in children, and have some form of regulatory approval or marking for this form of use. They also have randomized controlled trial research data supporting their efficacy, unless otherwise noted. It is up to the individual eye care practitioner to be aware of regulatory requirements for prescribing in their country of practice, and also be aware that not all products are available in all countries. Eyerising-International-myopia-management-device-rlrl-705x1024.jpgEyerising Myopia Management Device

Enormous thanks to our visionary sponsors

Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.